WRPWM
RXRX icon

Werba Rubin Papier Wealth Management’s Recursion Pharmaceuticals RXRX Stock Holding History

Werba Rubin Papier Wealth Management’s Portfolio RXRX Stock Details RXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$114K Sell
37,155
-839
-2% -$3.24K 0.02% 276
2025
Q4 		$155K Buy
+37,994
New +$188K 0.04% 229

Other funds holding RXRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SoftBank Group
SoftBank Group Tokyo, Japan $11.4B AUM 27.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MCMU
MIC Capital Management (UK) London, United Kingdom $352M AUM 0.23% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Werba Rubin Papier Wealth Management's RXRX Position: Q1 2026 in Review

Werba Rubin Papier Wealth Management reduced its Recursion Pharmaceuticals (RXRX) stake by 2.2% in Q1 2026, selling an estimated $3.24K and leaving 37,155 shares worth $114K. The position accounts for 0.02% of the portfolio, ranked #276.

Werba Rubin Papier Wealth Management first reported a position in RXRX in Q4 2025 and has held it in 2 quarters since. The position peaked at $155K in Q4 2025. 334 funds tracked by Wall St. Rank hold RXRX as of Q1 2026.

  • Werba Rubin Papier Wealth Management held 37,155 shares of Recursion Pharmaceuticals worth $114K as of Q1 2026.
  • Werba Rubin Papier Wealth Management sold 839 Recursion Pharmaceuticals shares in Q1 2026, an estimated $3.24K.
  • Recursion Pharmaceuticals made up 0.02% of Werba Rubin Papier Wealth Management's portfolio in Q1 2026, its #276 holding.
  • Werba Rubin Papier Wealth Management first reported a position in Recursion Pharmaceuticals in Q4 2025 and has held it in 2 quarters since.
  • Werba Rubin Papier Wealth Management's Recursion Pharmaceuticals position peaked at $155K in Q4 2025.
  • 334 funds tracked by Wall St. Rank held Recursion Pharmaceuticals as of Q1 2026.

Based on Werba Rubin Papier Wealth Management's 13F filing for Q1 2026, filed 12 May 2026.